476 related articles for article (PubMed ID: 27623868)
1. Epigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications.
Qin H; Zhao A; Zhang C; Fu X
Stem Cell Rev Rep; 2016 Dec; 12(6):708-720. PubMed ID: 27623868
[TBL] [Abstract][Full Text] [Related]
2. Somatic cell reprogramming as a tool for neurodegenerative diseases.
Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
Firas J; Liu X; Lim SM; Polo JM
Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
[TBL] [Abstract][Full Text] [Related]
4. Small molecules for reprogramming and transdifferentiation.
Qin H; Zhao A; Fu X
Cell Mol Life Sci; 2017 Oct; 74(19):3553-3575. PubMed ID: 28698932
[TBL] [Abstract][Full Text] [Related]
5. Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.
Biswas D; Jiang P
Int J Mol Sci; 2016 Feb; 17(2):226. PubMed ID: 26861316
[TBL] [Abstract][Full Text] [Related]
6. Direct cell reprogramming: approaches, mechanisms and progress.
Wang H; Yang Y; Liu J; Qian L
Nat Rev Mol Cell Biol; 2021 Jun; 22(6):410-424. PubMed ID: 33619373
[TBL] [Abstract][Full Text] [Related]
7. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
Polak U; Li Y; Butler JS; Napierala M
Stem Cells Dev; 2016 Dec; 25(23):1788-1800. PubMed ID: 27615158
[TBL] [Abstract][Full Text] [Related]
8. Progress in the reprogramming of somatic cells.
Ma T; Xie M; Laurent T; Ding S
Circ Res; 2013 Feb; 112(3):562-74. PubMed ID: 23371904
[TBL] [Abstract][Full Text] [Related]
9. Divergent reprogramming routes lead to alternative stem-cell states.
Tonge PD; Corso AJ; Monetti C; Hussein SM; Puri MC; Michael IP; Li M; Lee DS; Mar JC; Cloonan N; Wood DL; Gauthier ME; Korn O; Clancy JL; Preiss T; Grimmond SM; Shin JY; Seo JS; Wells CA; Rogers IM; Nagy A
Nature; 2014 Dec; 516(7530):192-7. PubMed ID: 25503232
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
11. Chemical reprogramming and transdifferentiation.
Xie X; Fu Y; Liu J
Curr Opin Genet Dev; 2017 Oct; 46():104-113. PubMed ID: 28755566
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
Xie M; Tang S; Li K; Ding S
Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
[TBL] [Abstract][Full Text] [Related]
13. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
Brix J; Zhou Y; Luo Y
J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
[TBL] [Abstract][Full Text] [Related]
14. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
Ebrahimi B
Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
[TBL] [Abstract][Full Text] [Related]
15. Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.
Hawkins KE; Moschidou D; Faccenda D; Wruck W; Martin-Trujillo A; Hau KL; Ranzoni AM; Sanchez-Freire V; Tommasini F; Eaton S; De Coppi P; Monk D; Campanella M; Thrasher AJ; Adjaye J; Guillot PV
Mol Ther; 2017 Feb; 25(2):427-442. PubMed ID: 28153093
[TBL] [Abstract][Full Text] [Related]
16. Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion.
Velychko S; Kang K; Kim SM; Kwak TH; Kim KP; Park C; Hong K; Chung C; Hyun JK; MacCarthy CM; Wu G; Schöler HR; Han DW
Cell Rep; 2019 Apr; 27(1):30-39.e4. PubMed ID: 30943410
[TBL] [Abstract][Full Text] [Related]
17. Role of small molecules as drug candidates for reprogramming somatic cells into induced pluripotent stem cells: A comprehensive review.
Rehman A; Fatima I; Noor F; Qasim M; Wang P; Jia J; Alshabrmi FM; Liao M
Comput Biol Med; 2024 Jul; 177():108661. PubMed ID: 38810477
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of somatic cell reprogramming.
Wang Y; Bi Y; Gao S
Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984
[TBL] [Abstract][Full Text] [Related]
19. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
Wang AYL
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
[TBL] [Abstract][Full Text] [Related]
20. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors.
Maza I; Caspi I; Zviran A; Chomsky E; Rais Y; Viukov S; Geula S; Buenrostro JD; Weinberger L; Krupalnik V; Hanna S; Zerbib M; Dutton JR; Greenleaf WJ; Massarwa R; Novershtern N; Hanna JH
Nat Biotechnol; 2015 Jul; 33(7):769-74. PubMed ID: 26098448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
